Published in AIDS Weekly, October 6th, 2003
The grant allows Landay and his international team of researchers to test three different assays to determine which best assesses CD4 cell counts in HIV-positive patients in rural or underdeveloped countries.
Landay said one of the big problems facing underdeveloped countries is finding a test that can tell physicians or public health care workers when an HIV-positive patient's CD4 cell count falls under 200, which is when the patient needs antiviral therapy.
For this study, Landay's team...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.